View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AA61 Publication ID: Spring 2009 
Title: Electronic Prescriptions for Controlled Substances 
Abstract: DEA is revising its regulations to permit DEA-registered prescribers to write and sign prescriptions electronically. These revised regulations would be in addition to, not a replacement of, the existing rules. These regulations are needed to give pharmacies, hospitals, and practitioners the ability to use modern technology for controlled substance prescriptions, while maintaining the closed system of distribution of controlled substances dispensing. 
Agency: Department of Justice(DOJ)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300    21 CFR 1306    21 CFR 1311   
Legal Authority: 21 USC 802    21 USC 821    21 USC 827    21 USC 829    21 USC 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  03/05/2001  66 FR 13274   
NPRM  06/27/2008  73 FR 36722   
NPRM Comment Period End  09/25/2008    
Final Rule  09/00/2009    
Additional Information: DEA-218
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
Public Comment URL: www.deadiversion.usdoj.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Mark W. Caverly
Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7297
Email: dea.diversion.policy@usdoj.gov